References
- Cashman JR. Structural and catalytic properties of the mammalian flavin-containing monooxygenase. Chem Res Toxicol 8: 165- 181, 1995 https://doi.org/10.1021/tx00044a001
- Cashman JR. Flavin monooxygenases. In: Ioannides C ed, Enzyme systems that metabolize drugs and other xenobiotics, John Wiley & Sons, London, UK, pp 67-93, 2002a
- Cashman JR. Human flavincontaining monooxygenase (form 3): polymorphisms and variations in chemical metabolism. Pharmacogenomics 3: 325-339, 2002b https://doi.org/10.1517/14622416.3.3.325
- Chung WG, Cha YN. Oxidation of caffeine to theobromine and theophylline is catalyzed primarily by flavin-containing monooxygenase in liver microsomes. Biochem Biophys Res Commun 235: 685-688, 1997 https://doi.org/10.1006/bbrc.1997.6866
- Chung WG, Roh KH, Kim HM, Cha YN. Involvement of CYP3A1, 2B1, and 2E1 in C-8 hydroxylation and CYP1A2 and flavincontaining monooxygenase in N-demethylation of caffeine: identified by using inducer treated rat liver microsomes that are characterized with testosterone metabolic patterns. Chem Biol Interact 113: 1-14, 1998 https://doi.org/10.1016/S0009-2797(97)00109-9
- Chung WG, Kang JH, Roh HK, Lee KH, Park CS, Cha YN. Assessment of flavin-containing monooxygenase (FMO) activity by determining urinary ratio of theobromine and caffeine in a Korean population after drinking a cup of coffee. Korean J Physiol Pharmacol 3: 207-213, 1999
- Chung WG, Kang JH, Park CS, Cho MH, Cha YN. Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism. Clin Pharmacol Ther 67: 258-266, 2000 https://doi.org/10.1067/mcp.2000.104617
- Dolphin CT, Cullingford TE, Shephard EA, Smith RL, Phillips IR. Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavincontaining monooxygenase family of man, FMO1, FMO3 and FMO4. Eur J Biochem 235: 683-689, 1996 https://doi.org/10.1111/j.1432-1033.1996.00683.x
- Dolphin CT, Janmohamed A, Smith RL, Shephard EA, Phillips IR. Missense mutation in flavin-containing monooxygenase 3 gene, FMO3, underlies fish-odor syndrome. Nature Genetics 17: 491- 494, 1997a https://doi.org/10.1038/ng1297-491
- Dolphin CT, Riley JH, Smith RL, Shephard EA, Phillips IR. Structural organization of the human flavin-containing monooxygenase gene (FMO3), the favored candidate for fish-odor syndrome, determined directly from genomic DNA. Genomics 46:260-267, 1997b https://doi.org/10.1006/geno.1997.5031
- Kang JH, Chung WG, Lee KH, Park CS, Kang JS, Shin IC, Roh HK, Dong MS, Baek HM, Cha YN. Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FMO3 gene mutations in a Korean population. Pharmacogenetics 10: 67-78, 2000 https://doi.org/10.1097/00008571-200002000-00009
- Lomri N, Gu Q, Cashman JR. Molecular cloning of the flavincontaining monooxygenase (form II) cDNA from adult human liver. Proc Natl Acad Sci 89: 685-1689, 1992
- Lomri N, Yang ZC, Cashman JR. Regio- and stereoselective oxygenations by adult human liver flavin-containing monooxygenase 3. Comparison with forms 1 and 2. Chem Res Toxicol 6: 800-807, 1993 https://doi.org/10.1021/tx00036a008
- Nagata T, Williams DE, Ziegler DM. Substrate specificities of rabbit lung and porcine liver flavin-containing monooxygenases: Differences due to substrate specificity. Chem Res Toxicol 3: 372- 376, 1990 https://doi.org/10.1021/tx00016a016
- Oliver CF, Modi S, Sutcliffe MJ, Primrose WU, Lian LY, Robert GC. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation. Biochemistry 36: 1567-1572, 1997 https://doi.org/10.1021/bi962826c
- Oscarson M, Hidestrand M, Johansson I, Ingelman-Sundberg M. A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alteration in enzyme function. Mol Pharmacol 52: 1034- 1040, 1997 https://doi.org/10.1124/mol.52.6.1034
- Overby LH, Carver GC, Philpot RM. Quantitation and kinetic properties of hepatic microsomal and recombinant flavincontaining monooxygenases 3 and 5 from humans. Chem Biol Interact 106:29-45, 1997 https://doi.org/10.1016/S0009-2797(97)00055-0
- Park CS, Chung WG, Kang JH, Roh HK, Lee KH, Cha YN. Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population. Pharmacogenetics 9: 155-164, 1999
- Treacy EP, Akerman BR, Chow LML, Youil R, Bibeau C, Lin J, Bruce AG, Knight M, Danks DM, Cashman JR, Forrest SM. Mutations of the flavin-containing monooxygenase gene (FMO3) cuase trimethylaminuria, a defect in detoxication. Hum Mol Genet 7: 839-845, 1998 https://doi.org/10.1093/hmg/7.5.839
- Treacy EP, Akerman BR, Chow LML, Youil R, Bibeau C, Lin J, Bruce AG, Knight M, Danks DM, Cashman JR, Forrest SM. Mutations of the flavin-containing monooxygenase gene (FMO3) cuase trimethylaminuria, a defect in detoxication. Hum Mol Genet 7: 839-845, 1998 https://doi.org/10.1093/hmg/7.5.839
- Ziegler DM. Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metab Rev 19: 1-32, 1988 https://doi.org/10.3109/03602538809049617
- Ziegler DM. Flavin-containing monooxygenase: enzyme adapted for multisubstrate specificity. Trends Pharmacol Sci 11: 321-324, 1990 https://doi.org/10.1016/0165-6147(90)90235-Z